Driehaus Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Driehaus Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-115,563	Closed	-$6.07M	–	689
2016 Q3	$6.07M	Sell	115,563 -20,261	-15%	-$968K	0.21%	106
2016 Q2	$5.62M	Sell	135,824 -130,001	-49%	-$5.65M	0.2%	112
2016 Q1	$10.8M	Sell	265,825 -32,041	-11%	-$1.1M	0.35%	57
2015 Q4	$12.4M	Buy	297,866 +80,912	+37%	+$2.71M	0.42%	54
2015 Q3	$3.34M	Sell	216,954 -24,892	-10%	-$535K	0.12%	190
2015 Q2	$6.01M	Sell	241,846 -3,142	-1%	-$70K	0.21%	108
2015 Q1	$5.6M	Buy	244,988 +164,612	+205%	+$4.15M	0.19%	135
2014 Q4	$2.17M	Buy	+80,376	New	+$1.38M	0.09%	291

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Driehaus Capital Management's FPRX Position: Q4 2016 in Review

Driehaus Capital Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2016, closing a stake of 115,563 shares — an estimated $6.07M sold.

Driehaus Capital Management first reported a position in FPRX in Q4 2014 and held it in 8 quarters. The position peaked at $12.4M in Q4 2015. 172 funds tracked by Wall St. Rank hold FPRX as of Q4 2016.

Driehaus Capital Management reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Driehaus Capital Management sold 115,563 Five Prime Therapeutics, Inc. shares in Q4 2016, an estimated $6.07M.
Driehaus Capital Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 8 quarters.
Driehaus Capital Management's Five Prime Therapeutics, Inc. position peaked at $12.4M in Q4 2015.
172 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2016.

Based on Driehaus Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.